Tuesday, March 1, 2022: Life Sciences

The U.S. Patent and Trademark Office ruled that the Broad Institute of MIT and Harvard owns the rights to the genome editing technology CRISPR. The decision invalidates patent rights UC Berkeley granted gene-editing companies developing human therapies. It also means...

Tuesday, March 1, 2022: Payers

Cigna announced it plans to invest $450 million in its venture capital arm as part of its strategy to increase the company’s shareholder value and deliver long-term growth. The company will focus on contributing to bolt-on or tuck-in acquisitions along with...

Tuesday, March 1, 2022: Providers

A working paper from the National Bureau of Economic Research found that receiving care from an expensive hospital in a concentrated market increases spending but has no detectable effect on mortality. However, the relationship between higher prices and lower...